About Us
Introduction to Biosun Pharmed
Biosun Pharmed, as a knowledge-based company and one of the subsidiaries of the Barekat Pharmaceutical Group, commenced its operations in 2013 with the motto "The Chain of Life: From Prevention to Treatment". The company’s scope of activity includes Research and Development (R&D) and the production of biosimilars, vaccines, monoclonal antibodies (mAbs), and biological and peptide drugs. This company operates in three centers: the R&D site and Peptide API production site and quality control laboratory (Biosun Darou) in Yaftabad; the main manufacturing plant in Barekat Pharmaceutical Industrial City in Alborz Province; and the headquarters in Tehran.
Biosun Pharmed strives to utilize knowledge, expertise, and capabilities by employing the country's youth as human capital to take an effective step toward producing high-quality and affordable pharmaceutical products. This effort aims to facilitate patient access to medication, achieve national self-sufficiency from imports, reduce foreign currency expenditure, and elevate the country's health standards.
Human Papillomavirus Vaccine
Human Papillomavirus Vaccine
Product Categories
Classification of Biosun Pharmed's Major Products
Production Sites
From Research to Industrial Production; Equipped with Modern Technology and Global Standards
Biosimilar and mAb Production Plant
Specialized unit for the production of biosimilar drugs and monoclonal antibodies (mAb).
Peptide Drug Production Plant
Manufacturing center for peptide drugs featuring innovative formulations and rigorous quality control.
R&D and API Production Site
Center for the research and development of new formulations and the production of Active Pharmaceutical Ingredients (APIs) to enhance quality.
Largest Specialized Pharmaceutical City in Iran
Barkat Pharmaceutical Industrial Park
The Largest Specialized Pharmaceutical City in Iran
Barekat Pharmaceutical Industrial City, as the largest specialized pharmaceutical hub in the region, was founded to create a suitable platform for the development of the pharmaceutical industry in the Islamic Republic of Iran. Key goals include the expansion and centralization of R&D centers and advanced pharmaceutical factories. Other objectives involve meeting the country's medicinal needs, attracting international knowledge, capital, and partnerships, and developing pharmaceutical exports. This industrial park covers approximately 200 hectares, with 100 hectares dedicated to 205 industrial and knowledge-based plots.
Biosun Investors
SUPPORTING PATIENTS
Biosun Pharmed provides various programs for support, education, and quality of life improvement to facilitate patient access to modern treatments.
News and Updates
Latest from the Biosun Pharmed Complex
Pharmacy in Iran
Muhammad ibn Zakariya al-Razi (251–313 AH) was a Persian physician, philosopher, and chemist who authored enduring works in medicine, chemistry, and philosophy. He is renowned as the discoverer of alcohol and sulfuric acid. According to George Sarton (the father of the history of science), Razi was the greatest physician of Islam and the Middle Ages. In the West, this Persian scientist was known as the "Arabic Galen" because he wrote his books in Arabic. In honor of Razi's immense contributions to pharmacy, August 27th (the 5th of Shahrivar) is designated as Pharmacist's Day.
In 1850 (1229 SH), Dar ul-Funun was established through the efforts of Amir Kabir to advance sciences, featuring an Italian pharmacy teacher in the medical department. In 1918 (1297 SH), medical classes were separated into the Superior School of Medicine, and in 1922 (1301 SH), the School of Pharmacy was formally founded.